메뉴 건너뛰기
Heart Lung and Circulation
Volumn 20, Issue 11, 2011, Pages 688-690
Guidelines for the Diagnosis and Management of Hypertrophic Cardiomyopathy
Author keywords

Clinical; Genetics; Guidelines; Hypertrophic cardiomyopathy
Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;
EID: 80054095449     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.07.017     Document Type: Review
Times cited : (24)
References (7)
  • 1
    • 13444281662 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: from " heart tumour" to complex molecular genetic disorder
    • Doolan A., Nguyen L., Semsarian C. Hypertrophic cardiomyopathy: from " heart tumour" to complex molecular genetic disorder. Heart Lung Circ 2004, 13:15-25.
    • (2004) Heart Lung Circ , vol.13 , pp. 15-25
    • Doolan, A.1    Nguyen, L.2    Semsarian, C.3
  • 2
    • 33646757738 scopus 로고    scopus 로고
    • Compound and double mutations in hypertrophic cardiomyopathy patients: implications for genetic testing and counselling
    • Ingles J., Doolan A., Chiu C., Seidman J.G., Seidman C.E., Semsarian C. Compound and double mutations in hypertrophic cardiomyopathy patients: implications for genetic testing and counselling. J Med Genet 2005, 42:e59.
    • (2005) J Med Genet , vol.42
    • Ingles, J.1    Doolan, A.2    Chiu, C.3    Seidman, J.G.4    Seidman, C.E.5    Semsarian, C.6
  • 3
    • 75949086359 scopus 로고    scopus 로고
    • Multiple mutations in genetic cardiovascular disease: a marker of disease severity?
    • Kelly M., Semsarian C. Multiple mutations in genetic cardiovascular disease: a marker of disease severity?. Circ Cardiovasc Genet 2009, 2:182-190.
    • (2009) Circ Cardiovasc Genet , vol.2 , pp. 182-190
    • Kelly, M.1    Semsarian, C.2
  • 4
    • 33845913222 scopus 로고    scopus 로고
    • The genetic basis of hypertrophic cardiomyopathy
    • Lind J.M., Chiu C., Semsarian C. The genetic basis of hypertrophic cardiomyopathy. Exp Rev Cardiovasc Ther 2006, 4(6):927-934.
    • (2006) Exp Rev Cardiovasc Ther , vol.4 , Issue.6 , pp. 927-934
    • Lind, J.M.1    Chiu, C.2    Semsarian, C.3
  • 5
    • 34547188258 scopus 로고    scopus 로고
    • Prevention of sudden cardiac death and selection of patients for implantable cardioverter-defibrillators in hypertrophic cardiomyopathy
    • Maron B.J., SpiritoP, Shen W.K., Haas T.S., Formisano F., Link M.S., et al. Prevention of sudden cardiac death and selection of patients for implantable cardioverter-defibrillators in hypertrophic cardiomyopathy. JAMA 2007, 298:405-412.
    • (2007) JAMA , vol.298 , pp. 405-412
    • Maron, B.J.1    Spirito, P.2    Shen, W.K.3    Haas, T.S.4    Formisano, F.5    Link, M.S.6
  • 6
    • 67649599134 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance
    • Maron M.S., Maron B.J., Harrigan C., Buros J., Gibson C.M., Olivotto I., et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 14 2009, 54(3):220-228.
    • (2009) J Am Coll Cardiol 14 , vol.54 , Issue.3 , pp. 220-228
    • Maron, M.S.1    Maron, B.J.2    Harrigan, C.3    Buros, J.4    Gibson, C.M.5    Olivotto, I.6
  • 7
    • 84857119885 scopus 로고    scopus 로고
    • http://www.registry.centenary.org.au/p/resources/hcm/.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.